$322 Million is the total value of AIGH Capital Management LLC's 98 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 150.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
New | ADTRAN HOLDINGS INC | $22,733,000 | – | 1,161,019 | +100.0% | 7.06% | – | |
MTRN | Buy | MATERION CORP | $19,295,000 | +44.4% | 241,189 | +33.1% | 6.00% | +70.6% |
AVNW | Buy | AVIAT NETWORKS INC | $14,674,000 | +43.7% | 535,918 | +31.4% | 4.56% | +69.6% |
TELA | Buy | TELA BIO INC | $13,033,000 | +504.5% | 1,529,669 | +399.1% | 4.05% | +614.3% |
INDI | New | INDIE SEMICONDUCTOR INC | $10,634,000 | – | 1,452,766 | +100.0% | 3.30% | – |
ANIP | Buy | ANI PHARMACEUTICALS INC | $10,105,000 | +39.3% | 314,406 | +28.6% | 3.14% | +64.5% |
PRTK | Buy | PARATEK PHARMACEUTICALS INC | $9,990,000 | +52.8% | 3,887,172 | +14.8% | 3.10% | +80.5% |
ICAD | Buy | ICAD INC | $3,686,000 | -32.3% | 1,755,634 | +29.0% | 1.15% | -20.0% |
MDNA | Buy | MEDICENNA THERAPEUTICS CORP | $3,193,000 | +20.6% | 3,850,154 | +69.4% | 0.99% | +42.5% |
APEN | New | APOLLO ENDOSURGERY INC | $2,802,000 | – | 508,536 | +100.0% | 0.87% | – |
EOLS | Buy | EVOLUS INC | $1,610,000 | -19.6% | 200,000 | +15.9% | 0.50% | -5.1% |
New | CAPSTONE GREEN ENERGY CORP | $1,593,000 | – | 900,000 | +100.0% | 0.50% | – | |
OSMT | Buy | RVL PHARMACEUTICALS PLC | $1,553,000 | +1238.8% | 739,531 | +770.1% | 0.48% | +1458.1% |
Buy | CONTEXT THERAPEUTICS INC | $1,434,000 | +20.7% | 1,291,771 | +8.4% | 0.45% | +42.5% | |
ADVM | New | ADVERUM BIOTECHNOLOGIES INC | $1,140,000 | – | 1,200,000 | +100.0% | 0.35% | – |
New | SOLENO THERAPEUTICS INC | $708,000 | – | 424,089 | +100.0% | 0.22% | – | |
New | CELLECTAR BIOSCIENCES INC | $586,000 | – | 174,422 | +100.0% | 0.18% | – | |
New | ABEONA THERAPEUTICS INC | $428,000 | – | 140,644 | +100.0% | 0.13% | – | |
CMBM | New | CAMBIUM NETWORKS CORP | $325,000 | – | 19,182 | +100.0% | 0.10% | – |
ATNX | New | ATHENEX INC | $269,000 | – | 1,000,134 | +100.0% | 0.08% | – |
NLSPW | New | NLS PHARMACEUTICS LTD*w exp 09/25/202 | $158,000 | – | 633,361 | +100.0% | 0.05% | – |
New | SAVERONE 2014 LTD*w exp 06/02/202 | $128,000 | – | 428,330 | +100.0% | 0.04% | – | |
CYTHW | New | CYCLO THERAPEUTICS INC*w exp 11/14/202 | $77,000 | – | 219,795 | +100.0% | 0.02% | – |
New | SAVERONE 2014 LTDcall | $42,000 | – | 141,364 | +100.0% | 0.01% | – | |
New | PARABELLUM ACQUISITION CORP*w exp 99/99/999 | $8,000 | – | 450,214 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
SCPHARMACEUTICALS INC | 15 | Q2 2024 | 8.5% |
IDEAL PWR INC | 14 | Q2 2024 | 2.5% |
FRANKLIN WIRELESS CORP | 14 | Q2 2024 | 2.9% |
LIGHTPATH TECHNOLOGIES INC | 13 | Q2 2024 | 3.0% |
MYOMO INC | 13 | Q2 2024 | 5.3% |
AVIAT NETWORKS INC | 12 | Q3 2023 | 6.8% |
THERATECHNOLOGIES INC | 11 | Q2 2023 | 2.9% |
MEDICENNA THERAPEUTICS CORP | 11 | Q3 2023 | 1.1% |
PARATEK PHARMACEUTICALS INC | 10 | Q1 2023 | 3.2% |
COGNITION THERAPEUTICS INC | 10 | Q2 2024 | 1.5% |
View AIGH Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Bridgeline Digital, Inc. | May 21, 2021 | 627,419 | 9.7% |
View AIGH Capital Management LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
N-PX | 2024-09-06 |
13F-HR | 2024-08-07 |
13F-HR | 2024-05-14 |
13F-HR | 2024-02-12 |
13F-HR | 2023-11-13 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-15 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-12 |
View AIGH Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.